arrow
R

Rafael Micán

Hospital Universitario La Paz
H指数:10
被引数:419

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-acting cabotegravir and rilpivirine in people with HIV and obesity: Real-world outcomes from the RELATIVITY cohort
2026-01-250
PRE
Beyond COVID-19 in People with HIV: specific miRNA Expression Profile Persist After SARS-CoV-2 Clearance

超越HIV感染者中的COVID-19:SARS-CoV-2清除后特异miRNA表达谱持续存在

2025-12-130
OAAI
Triglyceride–glucose index and FIB-4 score in relation to cardiovascular disease risk among people with HIV: a retrospective cohort study

甘油三酯–葡萄糖指数和FIB-4评分与HIV感染者心血管疾病风险的关系:一项回顾性队列研究

2025-11-060
OAAI
Antiretroviral treatment in people living with HIV with late diagnosis initiating ART with DTG/3TC or BIC/TAF/FTC: A real-world cohort analysis

人类免疫缺陷病毒感染者中晚期诊断者使用DTG/3TC或BIC/TAF/FTC启动抗逆转录病毒治疗:一项真实世界队列分析

2025-10-070
PRE
Impact of training healthcare professionals in the detection and management of neuropsychiatric comorbidities in people with HIV: The CONECTAR project in Spain

在HIV感染者中,对神经精神共病进行识别和管理的培训对医疗专业人员的影晌:西班牙CONECTAR项目

2025-02-240
PRE
Patterns of Sexualized Drug Use among Gay, Bisexual, and Other Men Who Have Sex with Men Living with HIV: Insights from a Comprehensive Study-The U-SEX-2 GESIDA 9416 Study
2023-11-244
OAAI
Changes in Quality of Sleep, Mood, and Other Neuropsychiatric Symptoms After Switching Dolutegravir/Lamivudine/Abacavir to Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in a Randomized Study of People With Human Immunodeficiency Virus With Poor Sleep Quality: GESIDA 10418
2022-08-068
OAAI
Impact of preexisting nucleos(t)ide reverse transcriptase inhibitor resistance on the effectiveness of bictegravir/emtricitabine/tenofovir alafenamide in treatment experience patients
AIDS
IF3.1
2022-07-0816
OAAI
Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)
2021-11-253
OAAI